We specialize in the development of next-generation biologics by integrating cutting-edge science with advanced engineering approaches. Our focus areas include:
- Identifying novel antibody targets to address a wide range of diseases, including cancer, bacterial infections, and viral illnesses
- Discovering biosimilar antibodies that replicate the safety and efficacy of blockbuster biologic drugs
- Engineering protein-based therapeutics, such as insulin and insulin-like molecules, to enhance treatment options and patient outcomes
Harnessing genetic and protein engineering, combined with breakthroughs in bioinformatics and artificial intelligence, to accelerate the development of human antibodies and protein pharmaceuticals